AFP and hepatocellular carcinoma: At the HCC time, there were no significant deviations from the initial baseline blood test results except for AFP levels in the de novo HCC group, which had a median of 50 (range 3.7–158) compared to a median of 9.5 (range 4.5–113) in the other group.